Global PEGylated Proteins Market Demand, Size 2023-2028

1. Global PEGylated Proteins Market Research Report 2023-2028 Author: Elena Anderson Marketing Manager IMARC Group © 2022 IMARC All Rights Reserved Copyright © IMARC Service Pvt Ltd. All Rights Reserved

2. About IMARC Group Report Description International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Global PEGylated Proteins Market Outlook 2023-2028 : As per the latest report by IMARC Group, titled "PEGylated Proteins Market by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028," the global PEGylated proteins market size reached US$ 1.16 Billion in 2022. The market value is projected to reach US$ 2.13 Billion by 2028, expanding at a CAGR of 10.16% during 2023-2028. PEGylation is the process of covalently attaching polyethylene glycol (PEG) molecules to proteins. It has revolutionized the field of therapeutic protein engineering and is extensively employed in the pharmaceutical industry. It offers numerous advantages, such as enhancing the properties and performance of therapeutic proteins. The production of PEGylated proteins involves chemically modifying the protein of interest with PEG chains, thereby altering its physicochemical properties. This modification imparts several beneficial characteristics, such as increased stability, reduced immunogenicity, prolonged half-life, and improved solubility, ultimately leading to improved therapeutic efficacy. One of its key benefits is the enhanced stability it provides to proteins, protecting them from degradation and denaturation. By shielding proteins from enzymatic degradation and immune recognition, PEGylation significantly extends their circulating half-life, allowing for less frequent dosing and improved patient compliance. Report Description

4. Report Description and Highlights Global PEGylated Proteins Market Outlook 2023-2028 : Moreover, the attachment of PEG chains to proteins can reduce their immunogenicity, minimizing adverse immune reactions and increasing the safety profile of therapeutic interventions. In comparison to conventional protein-based therapeutics, PEGylated proteins demonstrate improved pharmacokinetic properties, resulting in optimized drug delivery and expanded therapeutic window. The reduced renal clearance and prolonged circulation time of PEGylated proteins enable targeted drug delivery to specific tissues or cells, enhancing efficacy while minimizing systemic toxicity. Currently, it has found application in various therapeutic areas, including oncology, immunology, and hematology. Request a Free PDF Sample of the Report : https://www.imarcgroup.com/pegylated-proteins-market/requestsample Report Description

5. Report Description and Highlights Report Description Global PEGylated Proteins Market Trends: The global market for PEGylated proteins is primarily influenced by the growing prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, and the surging demand for targeted therapies. Moreover, the rising geriatric population has fueled the demand for innovative treatments, which is boosting the market growth. In confluence with this, significant advancements in biotechnology and protein engineering have led to the development of novel PEGylation techniques, enabling the modification of a wide range of proteins for various therapeutic applications, further propelling the market growth. Additionally, the increasing adoption of biologics, including PEGylated proteins, by healthcare providers and patients, the expanding research and development (R&D) activities in protein-based therapeutics, and the growing number of collaborations between pharmaceutical companies and academic institutions are contributing to the market growth. Apart from this, favorable regulatory environments and the increasing number of drug approvals for PEGylated protein-based therapies are creating a positive outlook for market growth. Besides this, the rising demand for personalized medicine and the escalating healthcare expenditure, coupled with the expanding biopharmaceutical industry, are fostering the market growth. In line with this, continuous technological advancements in drug delivery systems and the escalating focus on targeted drug delivery using PEGylated proteins are positively contributing to market growth. Other factors, such as the increasing awareness about the advantages of PEGylated proteins, including prolonged drug half-life, improved bioavailability, and reduced immunogenicity, and inflating consumer expenditure power, are accelerating the market growth. View Report TOC, Figures and Tables : https://www.imarcgroup.com/pegylated-proteins-market

6. Report Description and Highlights Report Description • Key Market Segmentation: • The report has segmented the Global PEGylated Proteins Market on the basis of type, component, deployment mode, organization size and vertical. • Product Insights: • Consumables • PEGylation Reagents • PEGylation Kits • Services • Protein Type Insights: • Colony Stimulating Factors • Interferons • Erythropoietin • mAbs • Recombinant Factor VII • Others

7. Report Description and Highlights • Application Insights: • Cancer Treatment • Hepatitis • Chronic Kidney Diseases • Hemophilia • Multiple Sclerosis • Gastrointestinal Disorders • Others • End User Insights: • Pharmaceutical and Biotechnology Companies • Contract Research Organizations • Academic and Research Institutes Report Description

8. Report Description and Highlights • Breakup by Region: • North America • Asia-Pacific • Europe • Latin America • Middle East and Africa • Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7070&flag=E Report Description

9. Report Description and Highlights • Competitive Landscape With Key Players: • The competitive landscape of the Global PEGylated Proteins Market has been studied in the report with the detailed profiles of the key players operating in the market. • Abcam plc • Biomatrik Inc. • Creative PEGWorks • Iris Biotech GmbH • JenKem Technology USA Inc. • Laysan Bio Inc. • NOF America Corporation (NOF Corporation) • Profacgen • Thermo Fisher Scientific Inc Report Description

10. Table of Contents Report Description 1   Preface 2   Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3   Executive Summary Introduction 4.1 Overview 4.2 Key Industry Trends

11. Table of Contents Report Description Global PEGylated Proteins Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast Market Breakup by Product 6.1 Consumables 6.1.1 Market Trends 6.1.2 Key Segments 6.1.2.1 PEGylation Reagents 6.1.2.2 PEGylation Kits 6.1.3 Market Forecast 6.2 Services Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/pegylated-proteins-market/toc

12. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

13. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

14. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

15. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com